Skip to main content
. Author manuscript; available in PMC: 2013 Sep 5.
Published in final edited form as: Clin Pharmacol Ther. 2008 May 21;84(3):362–369. doi: 10.1038/clpt.2008.89

Figure 5.

Figure 5

Program review. The program plan was reviewed by the Office for Human Research Protections (OHRP) and the Institutional Review Board (IRB). The IRB recommended further review from the standpoint of ethics, and the Ethics Review recommendations included the formation of a Community Advisory Board. The IRB, Ethics, and Community reviews resulted in program revisions, and these are ongoing.